Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer

References

• de Deus MouraRCarvalhoFMBacchiCEBreast cancer in very young women: clinicopathological study of 149 patients ≤25 years oldBreast201524446146725998784
   PubMedGoogle Scholar
• MillerJWKingJBJosephDARichardsonLCCenters for Disease Control and Prevention (CDC)Breast cancer screening among adult women behavioral risk factor surveillance system, United States, 2010MMWR Suppl2012612465022695463
   PubMedGoogle Scholar
• ReederJGVogelVGBreast cancer preventionCancer Treat Res200814114916418274088
   PubMedGoogle Scholar
• Collaborative Group on Hormonal Factors in Breast CancerBreast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the diseaseLancet2002360932818719512133652
   PubMed Web of Science ®Google Scholar
• ClappRWJacobsMMLoechlerELEnvironmental and occupational causes of cancer: new evidence 2005–2007Rev Environ Health200823113718557596
   PubMedGoogle Scholar
• KirshVAChiarelliAMEdwardsSATumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening programJ Natl Cancer Inst20111031294295021540443
   PubMedGoogle Scholar
• RiveraEGomezHChemotherapy resistance in metastatic breast cancer: the evolving role of ixabepiloneBreast Cancer Res201012Suppl 2S2
   PubMedGoogle Scholar
• EBCTCG (Early Breast Cancer Trialists’ Collaborative Group)McGalePTaylorCEffect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trialsLancet201438399352127213524656685
   PubMed Web of Science ®Google Scholar
• KohlerJSchulerMGaulerTCCirculating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patientsJ Cancer Res Clin Oncol2016142479580526687686
   PubMedGoogle Scholar
• WuYYangLZhaoJNuclear-enriched abundant transcript 1 as a diagnostic and prognostic biomarker in colorectal cancerMol Cancer20151419126552600
   PubMed Web of Science ®Google Scholar
• ToraihEAMohammedEAFarragSRamsisNHosnySPilot study of serum microRNA-21 as a diagnostic and prognostic biomarker in Egyptian breast cancer patientsMol Diagn Ther201519317919026063582
   PubMed Web of Science ®Google Scholar
• XuSYiXMZhouWQChengWGeJPZhangZYDownregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancerInt J Clin Exp Pathol2015811143351434426823749
   PubMed Web of Science ®Google Scholar
• BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
   PubMed Web of Science ®Google Scholar
• MacfarlaneLAMurphyPRMicroRNA: biogenesis, function and role in cancerCurr Genomics201011753756121532838
   PubMed Web of Science ®Google Scholar
• WangXCMaYMengPSHanJLYuHYBiLJmiR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6Oral Oncol201551767468225962939
   PubMed Web of Science ®Google Scholar
• WangMJLiYWangRDownregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancerInt J Colorectal Dis201328218318922885837
   PubMed Web of Science ®Google Scholar
• QiuSLinSHuDFengYTanYPengYInteractions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patientsJ Transl Med2013111023302469
   PubMed Web of Science ®Google Scholar
• ZhouJLiWGuoJLiGChenFZhouJDownregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinomaTumour Biol20163733561356926456956
   PubMedGoogle Scholar
• KangHKimCLeeHDownregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancerCell Death Differ201623348449526337669
   PubMedGoogle Scholar
• MillerABEarly detection of breast cancer in the emerging worldZentralbl Gynakol2006128419119516835812
   PubMedGoogle Scholar
• MousaviSMMontazeriAMohagheghiMABreast cancer in Iran: an epidemiological reviewBreast J200713438339117593043
   PubMed Web of Science ®Google Scholar
• JohnsonRHChienFLBleyerAIncidence of breast cancer with distant involvement among women in the United States, 1976 to 2009JAMA2013309880080523443443
   PubMed Web of Science ®Google Scholar
• DiabyVTawkRSanogoVXiaoHMonteroAJA review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancerBreast Cancer Res Treat20151511274025893588
   PubMed Web of Science ®Google Scholar
• van RoosmalenWLe DevedecSEGolaniOTumor cell migration screen identifies SRPK1 as breast cancer metastasis determinantJ Clin Invest201512541648166425774502
   PubMed Web of Science ®Google Scholar
• LiMZhangQWuLSerum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancerOncol Rep20143141961196724549225
   PubMedGoogle Scholar
• YuJJinLJiangLSerum miR-372 is a diagnostic and prognostic biomarker in patients with early colorectal cancerAnticancer Agents Med Chem201616442443126179262
   PubMed Web of Science ®Google Scholar
• SuZXZhaoJRongZHWuYGGengWMQinCKDiagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancerTumour Biol20143512121191212525416437
   PubMedGoogle Scholar
• YinZLWangYLGeSFReduced expression of miR-503 is associated with poor prognosis in cervical cancerEur Rev Med Pharmacol Sci201519214081408526592830
   PubMed Web of Science ®Google Scholar
• LuoMShenDZhouXChenXWangWMicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptorSurgery2013153683684723453369
   PubMed Web of Science ®Google Scholar
• ZuberiMMirRDasJExpression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological featuresClin Transl Oncol2015171077978726063644
   PubMed Web of Science ®Google Scholar
• ChenZTangZYHeYLiuLFLiDJChenXmiRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinomaOncol Res Treat2014371165866425427583
   PubMed Web of Science ®Google Scholar
• XiangJWuYLiDSmiR-584 suppresses invasion and cell migration of thyroid carcinoma by regulating the target oncogene ROCK1Oncol Res Treat201538943644026405762
   PubMed Web of Science ®Google Scholar
• ZuberiMKhanIMirRGandhiGRayPCSaxenaAUtility of serum miR-125b as a diagnostic and prognostic indicator and its alliance with a panel of tumor suppressor genes in epithelial ovarian cancerPLoS One2016114e015390227092777
   PubMed Web of Science ®Google Scholar
• WangYGaoXWeiFDiagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysisGene2014533138939724076132
   PubMed Web of Science ®Google Scholar
• XiaoBTanLHeBLiuZXuRMiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cellsJ Transl Med20131117223866847
   PubMed Web of Science ®Google Scholar
• SunCCLiSJZhangFHsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancerOncotarget2016716215102152626909600
   PubMed Web of Science ®Google Scholar